Emerging evidence suggests that some individuals develop nutritional deficiencies during treatment, whereas others experience biologically driven GLP-1 resistance.
Kanwal Fatima, PharmD, BCMAS
Advertisement
Kanwal Fatima, PharmD, BCMAS
📧 Email: [email protected]
đź”— LinkedIn: linkedin.com/in/kanwal-fatima-2a4016202
Articles by Kanwal Fatima, PharmD, BCMAS
As biomedical research output continues to grow, so does the demand for professionals who can accurately interpret data and communicate it responsibly to diverse audiences.
Advertisement
Latest Updated Articles
Why Some Patients Do Not Respond to GLP-1 TherapiesJune 2nd 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis on the Rise in the United States, Exceeding 450 Cases
2
Kidney Disease Rates Hold Steady for a Decade as Diabetes-Driven Cases Climb
3
Same-Day COVID-19 and Flu Vaccination Does Not Raise Adverse Event Risk, Large VA Study Finds
4
Reducing Recurrence in C Difficile Infection
5